Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease
- Author
- BARNES, Neil C; QIU, Yu-Sheng; PAVORD, Ian D; PARKER, Debbie; DAVIS, Peter A; JIE ZHU; JOHNSON, Malcolm; THOMSON, Neil C; JEFFERY, Peter K
[1] Department of Respiratory Medicine, London Chest Hospital, United Kingdom
[2] Lung Pathology Unit, Imperial College London at the Royal Brompton Hospital, London, United Kingdom
[3] Institute for Lung Health, Glenfield Hospital, Leicester, United Kingdom
[4] GlaxoSmithKline Research and Development Ltd, Greenford, Middlesex, England, United Kingdom
[5] Department of Respiratory Medicine, University of Glasgow, Glasgow, Scotland, United Kingdom
SC030005 Study Group, United Kingdom - Source
American journal of respiratory and critical care medicine. 2006, Vol 173, Num 7, pp 736-743, 8 p ; ref : 57 ref
- ISSN
- 1073-449X
- Scientific domain
- Pneumology
- Publisher
- American Lung Association, New York, NY
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- airway inflammation biopsy placebo sputum
- Keyword (fr)
- Antiasthmatique Antiinflammatoire Biopsie Bronchodilatateur Bronchopneumopathie obstructive Expectoration Fluticasone Inflammation Réanimation Salmétérol Soin intensif Maladie chronique Agoniste Appareil respiratoire pathologie Bronche pathologie Corticostéroïde Poumon pathologie Récepteur β2-adrénergique Stimulant β-adrénergique
- Keyword (en)
- Antiasthma agent Antiinflammatory agent Biopsy Bronchodilator Obstructive pulmonary disease Sputum Fluticasone Inflammation Resuscitation Salmeterol Intensive care Chronic disease Agonist Respiratory disease Bronchus disease Corticosteroid Lung disease β2-Adrenergic receptor β-Adrenergic receptor agonist
- Keyword (es)
- Agente antiasma Antiinflamatorio Biopsia Broncodilatador Broncopneumopatía obstructiva Expectoración Fluticasona Inflamación Reanimación Salmeterol Cuidado intensivo Agonista Aparato respiratorio patología Bronquio patología Corticoesteroide Pulmón patología Receptor β2-adrenérgico Estimulante β-adrenérgico
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02G Blood. Blood coagulation. Reticuloendothelial system
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B11 Pneumology / 002B11B Chronic obstructive pulmonary disease, asthma
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B27 Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy / 002B27B Intensive care medicine
- Discipline
- Anaesthesia. Reanimation. Transfusion. Cell therapy and gene therapy Pharmacological treatments Pulmonology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 17642160
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1164/rccm.200508-1321OC 
https://dx.doi.org/10.1164/rccm.200508-1321OC
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1164\/rccm.200508-1321OC\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:97:\"Antiinflammatory effects of salmeterol\/fluticasone propionate in chronic obstructive lung disease\";s:9:\"\u0000*\u0000jtitle\";s:58:\"American journal of respiratory and critical care medicine\";s:9:\"\u0000*\u0000stitle\";s:29:\"Am. j. respir. crit. care med\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"173\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"736\";s:8:\"\u0000*\u0000epage\";s:3:\"743\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1073-449X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"BARNES\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Neil C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:13:\"QIU, Yu-Sheng\";i:1;s:13:\"PAVORD, Ian D\";i:2;s:14:\"PARKER, Debbie\";i:3;s:14:\"DAVIS, Peter A\";i:4;s:7:\"JIE ZHU\";i:5;s:16:\"JOHNSON, Malcolm\";i:6;s:15:\"THOMSON, Neil C\";i:7;s:16:\"JEFFERY, Peter K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:97:\"Antiinflammatory effects of salmeterol\/fluticasone propionate in chronic obstructive lung disease\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:25:\"American Lung Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1164\/rccm.200508-1321OC\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:97:\"Antiinflammatory effects of salmeterol\/fluticasone propionate in chronic obstructive lung disease\";s:9:\"\u0000*\u0000jtitle\";s:58:\"American journal of respiratory and critical care medicine\";s:9:\"\u0000*\u0000stitle\";s:29:\"Am. j. respir. crit. care med\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"173\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"736\";s:8:\"\u0000*\u0000epage\";s:3:\"743\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1073-449X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"BARNES\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Neil C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:13:\"QIU, Yu-Sheng\";i:1;s:13:\"PAVORD, Ian D\";i:2;s:14:\"PARKER, Debbie\";i:3;s:14:\"DAVIS, Peter A\";i:4;s:7:\"JIE ZHU\";i:5;s:16:\"JOHNSON, Malcolm\";i:6;s:15:\"THOMSON, Neil C\";i:7;s:16:\"JEFFERY, Peter K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:97:\"Antiinflammatory effects of salmeterol\/fluticasone propionate in chronic obstructive lung disease\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:25:\"American Lung Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:26:\"10.1164\/rccm.200508-1321OC\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1164\/rccm.200508-1321OC\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:97:\"Antiinflammatory effects of salmeterol\/fluticasone propionate in chronic obstructive lung disease\";s:9:\"\u0000*\u0000jtitle\";s:58:\"American journal of respiratory and critical care medicine\";s:9:\"\u0000*\u0000stitle\";s:29:\"Am. j. respir. crit. care med\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"173\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"736\";s:8:\"\u0000*\u0000epage\";s:3:\"743\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1073-449X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"BARNES\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Neil C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:13:\"QIU, Yu-Sheng\";i:1;s:13:\"PAVORD, Ian D\";i:2;s:14:\"PARKER, Debbie\";i:3;s:14:\"DAVIS, Peter A\";i:4;s:7:\"JIE ZHU\";i:5;s:16:\"JOHNSON, Malcolm\";i:6;s:15:\"THOMSON, Neil C\";i:7;s:16:\"JEFFERY, Peter K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:97:\"Antiinflammatory effects of salmeterol\/fluticasone propionate in chronic obstructive lung disease\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:25:\"American Lung Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1164\/rccm.200508-1321OC\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:97:\"Antiinflammatory effects of salmeterol\/fluticasone propionate in chronic obstructive lung disease\";s:9:\"\u0000*\u0000jtitle\";s:58:\"American journal of respiratory and critical care medicine\";s:9:\"\u0000*\u0000stitle\";s:29:\"Am. j. respir. crit. care med\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"173\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"736\";s:8:\"\u0000*\u0000epage\";s:3:\"743\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1073-449X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"BARNES\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Neil C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:13:\"QIU, Yu-Sheng\";i:1;s:13:\"PAVORD, Ian D\";i:2;s:14:\"PARKER, Debbie\";i:3;s:14:\"DAVIS, Peter A\";i:4;s:7:\"JIE ZHU\";i:5;s:16:\"JOHNSON, Malcolm\";i:6;s:15:\"THOMSON, Neil C\";i:7;s:16:\"JEFFERY, Peter K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:97:\"Antiinflammatory effects of salmeterol\/fluticasone propionate in chronic obstructive lung disease\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:25:\"American Lung Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1164\/rccm.200508-1321OC\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:97:\"Antiinflammatory effects of salmeterol\/fluticasone propionate in chronic obstructive lung disease\";s:9:\"\u0000*\u0000jtitle\";s:58:\"American journal of respiratory and critical care medicine\";s:9:\"\u0000*\u0000stitle\";s:29:\"Am. j. respir. crit. care med\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"173\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"736\";s:8:\"\u0000*\u0000epage\";s:3:\"743\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1073-449X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"BARNES\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Neil C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:13:\"QIU, Yu-Sheng\";i:1;s:13:\"PAVORD, Ian D\";i:2;s:14:\"PARKER, Debbie\";i:3;s:14:\"DAVIS, Peter A\";i:4;s:7:\"JIE ZHU\";i:5;s:16:\"JOHNSON, Malcolm\";i:6;s:15:\"THOMSON, Neil C\";i:7;s:16:\"JEFFERY, Peter K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:97:\"Antiinflammatory effects of salmeterol\/fluticasone propionate in chronic obstructive lung disease\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:25:\"American Lung Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
